CRIS Q1 2018 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$14M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+15.8% YoY

Gross Profit

$2M94.8% margin

Operating Income

-$10M-401.5% margin

Net Income

-$11M-435.5% margin

EPS (Diluted)

$-6.50

QoQ Revenue Growth

-24.3%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$61M

Total Liabilities

$47M

Stockholders' Equity

$14M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+15.8%
Gross Profit	$2M	$2M	+15.8%
Operating Income	-$10M	-$15M	+34.2%
Net Income	-$11M	-$16M	+31.7%

Revenue Segments

Drug Development Royalty

$100,000100%